CN

Chandrakant Nanasaheb Bhosekar

Director Director DIN 00026895
DIN 00026895 First appointment Aug 1991 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 1991
Shareholding value β€’β€’β€’β€’ Premium profile

About Chandrakant Nanasaheb Bhosekar

Data last updated:

Chandrakant Nanasaheb Bhosekar was a Director at Mediorals Laboratories Private Limited (1991–2017) and Director at Cipla Global Limited (from 2009). The companies operate in Pharma.

DIN 00026895
Primary Designation Director
Industry Pharma
First Appointment 22 Aug 1991
Oldest Company Age 18 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Aug 19911985₹17.5 Lakh (FY 2016)Converted To Llp
Cipla Global Limited U24100MH2008PLC187824
Director12 Mar 20092008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cipla Global Limited
Mediorals Laboratories Private Limited
Premium access

Shareholding and investment profile for Chandrakant Nanasaheb Bhosekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandrakant Nanasaheb Bhosekar

Chandrakant Nanasaheb Bhosekar was first appointed on 22 Aug 1991 as Director at Mediorals Laboratories Private Limited. The most recent appointment on record is 12 Mar 2009 at Cipla Global Limited.

Chandrakant Nanasaheb Bhosekar held 2 earlier board appointments: Mediorals Laboratories Private Limited (Director, 22 Aug 1991 to 11 Feb 2017); Cipla Global Limited (Director, from 12 Mar 2009).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available